Incidence and mortality of thyroid cancer in China, 2008-2012
|
摘要
Objective: To analyze the incidence and mortality rates of thyroid cancer(TC) in China from 2008 to 2012.Methods: Incident and death cases of TC were retrieved from the National Central Cancer Registry(NCCR)database collecting from 135 cancer registries in China during 2008-2012. The crude incidence and mortality rates of TC were calculated by area(urban/rural), region(eastern, middle, western), gender and age group(0, 1-4, 5-9,…, 85+). China census in 2000 and world Segi's population were applied for age-standardized rates. Joinpoint(Version 4.6.0.0) model was used for time-trend analysis.Results: The crude incidence rate of TC was 7.56/100,000 which ranked the seventh in overall cancers. The agestandardized incidence rates by China population(ASIRC) and by World population(ASIRW) were 6.25/100,000 and 5.52/100,000, respectively. The crude mortality of TC in China was 0.52/100,000. The age-standardized mortality rates by Chinese standard population(ASMRC) and by world standard population(ASMRW) were0.34/100,000 and 0.32/100,000, respectively. Incidence and mortality rates of TC were higher in females than in males and higher in urban areas than in rural areas. Eastern areas had the highest incidence followed by middle and western areas. TC incidence increased dramatically after age of 15 years, then peaked at 14.08/100,000 in the group of 50-54 years and finally decreased sharply after 55 years old. TC mortality increased with age in population,reaching the peak of 5.09/100,000 in sub-population aged 85 years or older. TC incidence increased by 4.73 times from 2.40/100,000 in 2003 to 13.75/100,000 in 2012 with an average annual increase of 20%, while TC mortality only increased slightly around 0.32/100,000 from 0.26/100,000 to 0.36/100,000.Conclusions: Appropriate targeted prevention, early detection and treatment programs can be carried out to curb the rapid growth trend of TC and control the disease burden.
Objective: To analyze the incidence and mortality rates of thyroid cancer(TC) in China from 2008 to 2012.Methods: Incident and death cases of TC were retrieved from the National Central Cancer Registry(NCCR)database collecting from 135 cancer registries in China during 2008-2012. The crude incidence and mortality rates of TC were calculated by area(urban/rural), region(eastern, middle, western), gender and age group(0, 1-4, 5-9,…, 85+). China census in 2000 and world Segi's population were applied for age-standardized rates. Joinpoint(Version 4.6.0.0) model was used for time-trend analysis.Results: The crude incidence rate of TC was 7.56/100,000 which ranked the seventh in overall cancers. The agestandardized incidence rates by China population(ASIRC) and by World population(ASIRW) were 6.25/100,000 and 5.52/100,000, respectively. The crude mortality of TC in China was 0.52/100,000. The age-standardized mortality rates by Chinese standard population(ASMRC) and by world standard population(ASMRW) were0.34/100,000 and 0.32/100,000, respectively. Incidence and mortality rates of TC were higher in females than in males and higher in urban areas than in rural areas. Eastern areas had the highest incidence followed by middle and western areas. TC incidence increased dramatically after age of 15 years, then peaked at 14.08/100,000 in the group of 50-54 years and finally decreased sharply after 55 years old. TC mortality increased with age in population,reaching the peak of 5.09/100,000 in sub-population aged 85 years or older. TC incidence increased by 4.73 times from 2.40/100,000 in 2003 to 13.75/100,000 in 2012 with an average annual increase of 20%, while TC mortality only increased slightly around 0.32/100,000 from 0.26/100,000 to 0.36/100,000.Conclusions: Appropriate targeted prevention, early detection and treatment programs can be carried out to curb the rapid growth trend of TC and control the disease burden.
Objective: To analyze the incidence and mortality rates of thyroid cancer(TC) in China from 2008 to 2012.Methods: Incident and death cases of TC were retrieved from the National Central Cancer Registry(NCCR)database collecting from 135 cancer registries in China during 2008-2012. The crude incidence and mortality rates of TC were calculated by area(urban/rural), region(eastern, middle, western), gender and age group(0, 1-4, 5-9,…, 85+). China census in 2000 and world Segi's population were applied for age-standardized rates. Joinpoint(Version 4.6.0.0) model was used for time-trend analysis.Results: The crude incidence rate of TC was 7.56/100,000 which ranked the seventh in overall cancers. The agestandardized incidence rates by China population(ASIRC) and by World population(ASIRW) were 6.25/100,000 and 5.52/100,000, respectively. The crude mortality of TC in China was 0.52/100,000. The age-standardized mortality rates by Chinese standard population(ASMRC) and by world standard population(ASMRW) were0.34/100,000 and 0.32/100,000, respectively. Incidence and mortality rates of TC were higher in females than in males and higher in urban areas than in rural areas. Eastern areas had the highest incidence followed by middle and western areas. TC incidence increased dramatically after age of 15 years, then peaked at 14.08/100,000 in the group of 50-54 years and finally decreased sharply after 55 years old. TC mortality increased with age in population,reaching the peak of 5.09/100,000 in sub-population aged 85 years or older. TC incidence increased by 4.73 times from 2.40/100,000 in 2003 to 13.75/100,000 in 2012 with an average annual increase of 20%, while TC mortality only increased slightly around 0.32/100,000 from 0.26/100,000 to 0.36/100,000.Conclusions: Appropriate targeted prevention, early detection and treatment programs can be carried out to curb the rapid growth trend of TC and control the disease burden.
引文
1.Chen W,Sun K,Zheng R,et al.Cancer incidence and mortality in China,2014.Chin J Cancer Res2018;30:1-12.
2.Ferlay J,Soerjomataram I,Ervik M,et al.GLOBOCAN 2012:Estimated Cancer Incidence,Mortality and Prevalence Worldwide in 2012 v1.0.IARC CancerBase No.11.Internatioanl Agency for Research on Cancer,2013.Available online:http://globocan.iarc.fr/Pages/online.aspx.
3.He J,Chen W.2015 Chinese Cancer Resgistry Annual Report.Beijing:Tsinghua University Press,2017.
4.Li H,Du L,Zhu C,et al.Analysis of cancer incidence and mortality in Zhejiang Cancer Registries,2013.Zhongguo Zhong Liu(in Chinese)2017;26:8-17.
5.Parkin DM.The evolution of the population-based cancer registry.Nat Rev Cancer 2006;6:603-12.
6.Curade MP,Edwards B,Shin HR,et al.Cancer incidence in five continents.Volume IX.Lyon:IARCSci Publ 2007;No.160.
7.Liu S,Yang L,Yuan Y,et al.Cancer incidence in Beijing,2014.Chin J Cancer Res 2018;30:13-20.
8.Liu S,Chen Q,Guo L,et al.Incidence and mortality of lung cancer in China,2008-2012.Chin J Cancer Res 2018;30:580-7.
9.Statistical Research and Applications Branch in National Cancer Institute,USA.Joinpoint software.Available online:https://surveillance.cancer.gov/joinpoint/
10.Davies L,Welch HG.Current thyroid cancer trends in the United States.JAMA Otolaryngol Head Neck Surg 2014;140:317-22.
11.Lee TJ,Kim S,Cho HJ,et al.The incidence of thyroid cancer is affected by the characteristics of a healthcare system.J Korean Med Sci 2012;27:1491-8.
12.Yang L,Wang N.Research advances in the epidemiology of thyroid cancer.Zhuonghua Yu Fang Yi Xue Za Zhi(in Chinese)2014;48:744-8.
13.Dong F,Zhang B,Shan G.Distribution and risk factors of thyroid cancer in China.Zhongguo Ai Zheng Za Zhi(in Chinese)2016;26:47-51.
14.Wang JX,Zhang LA,Li BX,et al.Cancer incidence and risk estimation among medical X-ray workers in China,1950-1995.Health Phys 2002;82:455-66.
15.Yildiz SY,Berkem H,Yuksel BC,et al.The rising trend of papillary carcinoma in thyroidectomies:14-years of experience in a referral center of Turkey.World J Surg Oncol 2014;12:34.
16.Conzo G,Avenia N,Bellastella G,et al.The role of surgery in the current management of differentiated thyroid cancer.Endocrine 2014;47:380-8.
17.Mishra A,Meherotra R.Head and neck cancer:global burden and regional trends in India.Asian Pac JCancer Prev 2014;15:537-50.
18.Gong W,HU R,Luo S,et al.Analysis on incidence and mortality characteristics of thyroid cancer during2007 to 2011 in Zhejiang Province.Zhejiang Yu Fang Yi Xue(in Chinese)2014;26:433-7.
19.Kitahara CM,Gamborg M,Berrington de González A,et al.Childhood height and body mass index wereassociated with risk of adult thyroid cancer in a large cohort study.Cancer Res 2014;74:235-42.
20.Buchman L,Ashby S,Cannon BB,et al.Psychosocial distress in patients with thyroid cancer.Otolaryngol Head Neck Surg 2015;152:644-9.
21.Kweon SS,Shin MH,Chung IJ,et al.Thyroid cancer is the most common cancer in women,based on the data from population-based cancer registries,South Korea.Jpn J Clin Oncol 2013;43:1039-46.
2.Ferlay J,Soerjomataram I,Ervik M,et al.GLOBOCAN 2012:Estimated Cancer Incidence,Mortality and Prevalence Worldwide in 2012 v1.0.IARC CancerBase No.11.Internatioanl Agency for Research on Cancer,2013.Available online:http://globocan.iarc.fr/Pages/online.aspx.
3.He J,Chen W.2015 Chinese Cancer Resgistry Annual Report.Beijing:Tsinghua University Press,2017.
4.Li H,Du L,Zhu C,et al.Analysis of cancer incidence and mortality in Zhejiang Cancer Registries,2013.Zhongguo Zhong Liu(in Chinese)2017;26:8-17.
5.Parkin DM.The evolution of the population-based cancer registry.Nat Rev Cancer 2006;6:603-12.
6.Curade MP,Edwards B,Shin HR,et al.Cancer incidence in five continents.Volume IX.Lyon:IARCSci Publ 2007;No.160.
7.Liu S,Yang L,Yuan Y,et al.Cancer incidence in Beijing,2014.Chin J Cancer Res 2018;30:13-20.
8.Liu S,Chen Q,Guo L,et al.Incidence and mortality of lung cancer in China,2008-2012.Chin J Cancer Res 2018;30:580-7.
9.Statistical Research and Applications Branch in National Cancer Institute,USA.Joinpoint software.Available online:https://surveillance.cancer.gov/joinpoint/
10.Davies L,Welch HG.Current thyroid cancer trends in the United States.JAMA Otolaryngol Head Neck Surg 2014;140:317-22.
11.Lee TJ,Kim S,Cho HJ,et al.The incidence of thyroid cancer is affected by the characteristics of a healthcare system.J Korean Med Sci 2012;27:1491-8.
12.Yang L,Wang N.Research advances in the epidemiology of thyroid cancer.Zhuonghua Yu Fang Yi Xue Za Zhi(in Chinese)2014;48:744-8.
13.Dong F,Zhang B,Shan G.Distribution and risk factors of thyroid cancer in China.Zhongguo Ai Zheng Za Zhi(in Chinese)2016;26:47-51.
14.Wang JX,Zhang LA,Li BX,et al.Cancer incidence and risk estimation among medical X-ray workers in China,1950-1995.Health Phys 2002;82:455-66.
15.Yildiz SY,Berkem H,Yuksel BC,et al.The rising trend of papillary carcinoma in thyroidectomies:14-years of experience in a referral center of Turkey.World J Surg Oncol 2014;12:34.
16.Conzo G,Avenia N,Bellastella G,et al.The role of surgery in the current management of differentiated thyroid cancer.Endocrine 2014;47:380-8.
17.Mishra A,Meherotra R.Head and neck cancer:global burden and regional trends in India.Asian Pac JCancer Prev 2014;15:537-50.
18.Gong W,HU R,Luo S,et al.Analysis on incidence and mortality characteristics of thyroid cancer during2007 to 2011 in Zhejiang Province.Zhejiang Yu Fang Yi Xue(in Chinese)2014;26:433-7.
19.Kitahara CM,Gamborg M,Berrington de González A,et al.Childhood height and body mass index wereassociated with risk of adult thyroid cancer in a large cohort study.Cancer Res 2014;74:235-42.
20.Buchman L,Ashby S,Cannon BB,et al.Psychosocial distress in patients with thyroid cancer.Otolaryngol Head Neck Surg 2015;152:644-9.
21.Kweon SS,Shin MH,Chung IJ,et al.Thyroid cancer is the most common cancer in women,based on the data from population-based cancer registries,South Korea.Jpn J Clin Oncol 2013;43:1039-46.